April 23, 2026 · Form 4 insider transaction
Gagnon Robert E. sold 7,842 shares of Opus Genetics, Inc. at $5.18 per share, a transaction worth $40.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
The shares reported on this line were sold automatically on behalf of the Reporting Person, as required by the Company to satisfy tax withholding obligations that arose in connection with a vesting and settlement event from a restricted stock units award. This transaction does not represent a discretionary trade by the Reporting Person.; The price in column 4 represents the weighted average price. The shares were sold in multiple transactions at prices ranging from $5.1828 to $5.1901, inclusive. The Reporting Person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.